Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
EMD Serono
National Cancer Institute (NCI)
Astellas Pharma Inc
Janssen Research & Development, LLC
Montefiore Medical Center
IO Biotech
Merck Sharp & Dohme LLC
AstraZeneca
M.D. Anderson Cancer Center
University of Washington
Novartis
University of California, San Francisco
Pfizer
Daiichi Sankyo
Duke University
National Cancer Institute (NCI)
University of Kentucky
Hoffmann-La Roche
National Cancer Institute (NCI)
Jiangsu HengRui Medicine Co., Ltd.
EMD Serono
AstraZeneca
Thomas Jefferson University
Hoffmann-La Roche
AstraZeneca
MacroGenics
BeOne Medicines
Wake Forest University Health Sciences
University of Pittsburgh
Big Ten Cancer Research Consortium
Genentech, Inc.
Novartis
AstraZeneca
Dana-Farber Cancer Institute
Revolution Medicines, Inc.
BeOne Medicines
HUYABIO International, LLC.
Seagen Inc.
Massachusetts General Hospital
I-Mab Biopharma US Limited
Hoffmann-La Roche
Regeneron Pharmaceuticals
Fundación GECP
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Mayo Clinic
NRG Oncology
Daiichi Sankyo
Sotio Biotech Inc.